Initial intravenous immunoglobulin doses should be based on adjusted body weight in obese patients with primary immunodeficiency disorders
Crossref DOI link: https://doi.org/10.1186/s13223-017-0220-y
Published Online: 2017-12-06
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ameratunga, Rohan